To access this video please...

Expanding treatment horizons in SHPT and hyperkalaemia: translating evidence into practical patient benefits

Categories :

106

Organizer of the Symposium

Program:

  • Addressing the challenges of SHPT management in non-dialysis CKD patients: the evolving role of extended-release calcifediol (ERC)
  • Optimising the benefits of RAASi therapy in non-dialysis CKD patients: the importance of long-term potassium control

Experts:

  • Prof. Jan Kielstein (Germany)
  • Prof. Martin de Borst (The Netherlands)

Moderator:

  • tbd.

Broadcast:

September 19, 2020 – 12:30-13:15 (CET)

Organizer of the Symposium

Recommended